0001214659-23-016099.txt : 20231206 0001214659-23-016099.hdr.sgml : 20231206 20231206170242 ACCESSION NUMBER: 0001214659-23-016099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231101 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAZIMI A J CENTRAL INDEX KEY: 0001075050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 231470375 MAIL ADDRESS: STREET 1: 1207 17TH AVENUE SUITE 103 CITY: NASHVILLE STATE: TN ZIP: 37212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 marketforms-63723.xml PRIMARY DOCUMENT X0508 4 2023-11-01 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001075050 KAZIMI A J 1600 WEST END AVE. SUITE 1300 NASHVILLE TN 37203 true true true false Chairman and CEO 1 Common Stock 2023-11-01 5 L false E 55 1.85 A 5719196 D Common Stock 2023-11-02 5 L false E 55 1.97 A 5719251 D Common Stock 2023-11-03 5 L false E 55 2.06 A 5719306 D Common Stock 2023-11-06 5 L false E 55 2.03 A 5719361 D Common Stock 2023-11-07 5 L false E 19 2.01 A 5719380 D Common Stock 2023-11-08 5 L false E 55 2.00 A 5719435 D Common Stock 2023-11-09 5 L false E 55 1.82 A 5719490 D Common Stock 2023-11-10 5 L false E 55 1.77 A 5719545 D Common Stock 2023-11-13 5 L false E 46 1.75 A 5719591 D Common Stock 2023-11-14 5 L false E 55 1.73 A 5719646 D Common Stock 2023-11-15 5 L false E 55 1.78 A 5719701 D Common Stock 2023-11-16 5 L false E 13 1.73 A 5719714 D Common Stock 2023-11-17 5 L false E 55 1.83 A 5719769 D Common Stock 2023-11-20 5 L false E 53 1.70 A 5719822 D Common Stock 2023-11-21 5 L false E 25 1.76 A 5719847 D Common Stock 2023-11-22 5 L false E 55 1.74 A 5719902 D Common Stock 2023-11-27 5 L false E 72 1.86 A 5719974 D Common Stock 2023-11-28 5 L false E 25 1.68 A 5719999 D Common Stock 2023-11-29 5 L false E 32 1.73 A 5720031 D Common Stock 2023-11-30 5 L false E 62 1.66 A 5720093 D The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. A.J. Kazimi by /s/ John Hamm as attorney-in-fact 2023-12-06